Matt Trerotola
Analyst · KeyBanc Capital Markets. Your line is now open
Thanks, Kevin and good morning. 2018 has been a transformational year for Colfax during which we reshaped our company and established an even stronger foundation for our future. First, we finished the year with strong financial results including earnings growth of 33% placing us well ahead of the commitment we made in December of 2017. ESAB achieved strong and accelerating sales growth across all regions, including strong contributions from new products and the team has done a great job of protecting margins in a year of notable cost escalation. Our Howden business recovered from the market challenges of late 2017 and the team has gotten the business firmly back on a path to mid-teens segment margins. They've successfully grown sales in the faster growing industrial applications, which are now half of the business and Howden exits 2018 with strong momentum on both order growth and margins and as well placed for a strong performance in 2019. We have successfully driven restructuring actions within both of our businesses and delivered $37 million of restructuring cost savings. Our progress improving the vitality of both businesses shows the power of CBS and supports our margin and gross improvement. We completed the monetization of our fluid handling business at an attractive multiple of over 13 times EBITDA and completed four new bolt [sp] on acquisitions that strengthen and diversify our ESAB and handling businesses. We also announced that Colfax has entered into a definitive agreement to acquire DJO, a leading Global Orthopedic Solutions Company. This acquisition is consistent with our strategy to create a higher margin, faster growing and less cyclical company. To support our deleveraging plans and future growth investments, we're exploring strategic options for our Air & Gas handling business, including a potential sale. We believe this will be a very attractive asset to potential acquirers given all the progress made to strengthen and diversify the business. Moving to Slide 4, you can see the highlights from our fourth quarter results. Our operating performance within line with expectations and tax benefits contributed to our performance. Fabrication Technology if the strong sales growth from continued healthy market demand as well as new product launches and pricing actions completed throughout the year. Air & Gas Handling drove another quarter of double-digit order growth with industrial remaining very strong aftermarket accelerating and most end-use markets moving in a positive direction. We increased this business' margins through restructuring actions and a deeper application of our business system to improve operational execution. This month, we successfully completed the DJO acquisition financing that started in the fourth quarter. DJO is a global leader in the attractive growing orthopedic solutions market and we're excited about the potential to apply our business system to further improve the business' growth and profitability. On Slide 5, you can see ESAB's continued growth and continued growth trajectory. This was the eighth quarter in a row of core growth at ESAB side and we continue to show double-digit growth, both overall end core. While healthy margins around the world had been a positive factor in our growth, we also launched 11 new products in 2018, increased automation backlog and funnel and added some great acquisitions, Sandvik and GCE that are performing well. I was in Europe recently with the GCE team for our standard hundred-day review process. We already have a fast start there softly integrating our businesses in the welding market and identifying some exciting gas control growth plans in med tech and life sciences. During the quarter we had some translational currency headwinds from the strengthening USD predominantly in our Argentinian, Brazilian, and Russian businesses. On Slide 6 you can see ESAB's year-to-date and current quarter, year-over-year adjusted operating profit performance. The performance was in line with what I communicated on our outlook call in December. Margins of 11.6% excluding the October 2018 GCE acquisition finished the year in line with 2017. Now, as I've talked about on several calls now we had multiple sources of cost escalation during 2018 year do the pricing actions have delivered nearly five points of price to offset material and other inflation pressures. And as these price actions are only covering inflation, the businesses margin rates are being compressed by about 50 basis points both year-to-date and in the fourth quarter. As is this pressure, we would have had another year of solid margin expansion in this business. When we exclude the GCE acquisition from Q4 underlying adjusted operating margins were 11.2%. This is a solid step forward from Q3 and our team continues to execute price and productivity actions in Q4 to enter 2019 firmly on the right side of the 2018 price cost improvement curve. ESAB's margins are expected to take a step forward in 2019 as additional price in productivity actions flow through and the business has a clear path back to greater than 12% operating margins in the first half of 2019. The healthy margin expansion in our 2019 guidance is consistent with our path to mid-teens for this business. Slide 7 shows our continued progress reshaping the Air & Gas Handling business for a less cyclical, more profitable growth. In the fourth quarter, the business had 13% quarter order growth plus another couple of points from the recent ACI and ACH acquisitions. We continued to achieve strong growth in our strategic industrial applications as core industrial orders grew 18% in the quarter. Oil and gas orders grew sequentially and the profitability of new orders continues to improve. Mining orders grew organically 141% as we secured our large order in the quarter at good margin levels. Finally, our power markets remain stable and orders, as expected, stepped up sequentially in the fourth quarter. On Slide 8, the Air & Gas Handling segment core sales grew 11% in the quarter, supported by strong growth in industrial applications, and as expected, Howden performed strongly on margins in the fourth quarter which improved 230 basis points sequentially and 440 basis points year-over-year to 12.1%. This improvement came from price, productivity, restructuring, and strategic choices that we've made in oil and gas to focus on higher margin projects. Backlog end of the year is stronger than expected and both backlog size and margin levels support the guidance provided on our December outlook call. On Slide 9 I want to share with you how the Colfax business system helped us to drive margin improvement in Howden. Lead process improvement is often thought of as synonymous with manufacturing, but CBS is a holistic business system that helps us to continuously improve across all business activities. Policy deployment in the core tool in the CBS toolkit and arguably are our most powerful tool. Its purpose is to drive breakthrough change within our businesses to advance our strategies. A great example of the impact of policy deployment can be found in the improvements in Howden project management during 2018. In 2017 the Howden leadership team had identified the opportunity to drive improvements in project execution on large new build projects, which involved complex engineering solutions and teams around the world. Using policy deployment, the Howden team re-engineered their end and project management processes and build a stronger foundation for project execution. This resulted in 2018 improvements in milestone delivery, our margins and better working capital. These changes are now sustained standard work in the business. It's a great example of how our teams use CBS to deliver improved service to customers and improve financial results. On Slide 10 we provide an update on our strategic initiatives. The company recently completed the financing to support the acquisition of DJO and refinance existing bank loans. Of course, the teams did a great job of getting this completed quickly and at attractive terms. The DJO acquisition is progressing as expected. We completed regulatory filings and continue to target a Q1 close. Our experienced integration team is fully engaged and we're all working closely with the DJO team to ensure a smooth transition. I was with a senior DJO team in Dallas recently for their initial CBS training and both sides are excited about the opportunities ahead. The review of our Air & Gas Handling strategic options is well underway, Goldman Sachs and Barclay's are leading the efforts and we're moving with speed. Before I hand over to Chris, I want to comment on our strategic progress. We strengthen our ESAB and Howden businesses getting them on the solid paths to growth and mid-teens segment margins. The recent DJO new platform acquisition is entirely consistent with our strategic commitment to diversify and strengthen our portfolio. We also see exciting opportunities to further expand in med tech. In summary, we made a lot of strategic and operational progress in 2018 and I expect a very successful year for Colfax in 2019. Now, I'd like to hand it over to Chris who will discuss the financial results.